EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Cumulative exposure to tacrolimus is associated with increased risk of malignancy for solid organ transplant recipients

Sergio A Acuna, Xun Zhao, Maggie Jones-Carr, Graham Smith, Kyla Naylor, Bima J Hasjim, Shiyi Chen, An-Wen Chan, Nancy Baxter, S Joseph Kim, Mamatha Bhat

International Journal of Cancer · 2026

DOI: 10.1002/ijc.70343 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer, 2026. Verfasst von Sergio A Acuna und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Transplantation, Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama, USA. Hauptthemen laut MEDLINE: Tacrolimus, Organ Transplantation, Immunosuppressive Agents, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS, University Health Network.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Solid organ transplant recipients (SOTR) face elevated cancer risk due to prolonged immunosuppression. While higher tacrolimus exposure has been linked to de novo malignancies, the dose–response relationship remains unclear, prompting the need for population‐level, longitudinal investigations. To quantify the exposure‐response relationship between tacrolimus trough level and post‐transplant malignancy risk, we used a population‐based cohort study using linked administrative healthcare data from Ontario, Canada. All transplant recipients from January 1, 2008 to March 1, 2020 with ≥2 serum tacrolimus levels in the first year post‐transplant were included. Cumulative exposure to tacrolimus was treated as a (1) continuous variable, (2) by quartiles of exposure within the first year and (3) as time‐varying exposure beyond the first year; incidence of de novo malignancy was investigated using cause‐specific and subdistribution Cox regression models. Among the 5178 SOTRs, a total of 318 de novo malignancies (6.1%) and 332 deaths (6.4%) occurred. For every 20% increase in the cumulative tacrolimus trough level in the first year, a heightened risk of malignancy was observed (HR = 1.09, 95% CI: 1.02–1.17). For each 20% increase in cumulative tacrolimus trough level after 1 year, the risk of malignancy increased (HR = 1.08 [95% CI: 1.01–1.15]). Patients in the highest quartile of cumulative exposure (median 9–10 ng/mL) had a 47% greater risk of malignancy compared to those in the lowest quartile (median 5–6 ng/mL; HR = 1.47 [95% CI: 1.03–2.11]). These findings highlight the importance of carefully titrating tacrolimus and avoiding unnecessary prolonged high exposure, particularly during the critical first year post‐transplant.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TacrolimusOrgan TransplantationImmunosuppressive AgentsNeoplasmsTransplant RecipientsHumansFemaleMaleMiddle AgedOntarioRisk FactorsAgedAdultIncidenceCohort StudiesGraft Rejection

Stichwörter der Autor:innen

cancerimmunosuppressionsolid organ transplanttacrolimus

Substanzen

TacrolimusImmunosuppressive Agents

Autor:innen und Institutionen

  • Division of Transplantation, Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Ajmera Transplant Centre, University Health Network, Toronto, Ontario, Canada.
  • Division of Gastroenterology and Hepatology, McGill University Health Centre, Montreal, Quebec, Canada.
  • ICES Western, London Health Sciences Centre Research Institute, London, Ontario, Canada.
  • Department of Medicine, Western University, London, Ontario, Canada.
  • Department of Epidemiology & Biostatistics, Western University, London, Ontario, Canada.

Förderung

  • NIDDK NIH HHS
  • University Health Network

Zitieren

APA

Acuna, S. A., Zhao, X., Jones-Carr, M., Smith, G., Naylor, K., Hasjim, B. J., Chen, S., Chan, A. W., Baxter, N., Kim, S. J., & Bhat, M. (2026). Cumulative exposure to tacrolimus is associated with increased risk of malignancy for solid organ transplant recipients. International Journal of Cancer. https://doi.org/10.1002/ijc.70343

Vancouver

Acuna SA, Zhao X, Jones-Carr M, Smith G, Naylor K, Hasjim BJ, et al. Cumulative exposure to tacrolimus is associated with increased risk of malignancy for solid organ transplant recipients. International Journal of Cancer. 2026. doi:10.1002/ijc.70343

BibTeX
@article{Acuna2026,
  author = {Acuna, Sergio A and Zhao, Xun and Jones-Carr, Maggie and Smith, Graham and Naylor, Kyla and Hasjim, Bima J and Chen, Shiyi and Chan, An-Wen and Baxter, Nancy and Kim, S Joseph and Bhat, Mamatha},
  title = {Cumulative exposure to tacrolimus is associated with increased risk of malignancy for solid organ transplant recipients},
  journal = {International Journal of Cancer},
  year = {2026},
  doi = {10.1002/ijc.70343}
}
Kostenlos starten →